Anthony King
I am a freelance science journalist based in Dublin, Ireland. I cover a variety of topics in chemical and biological sciences, as well as science policy, health and innovation.
My articles have appeared in Nature, Science, Cell, Chemistry World, New Scientist, the Irish Times, New York Times, EMBO Reports, Chemistry & Industry and more.
I enjoy writing on a wide breadth of subjects, from antibiotics to petrochemicals, bumblebees to asteroid composition, palaeontology to brain development. Previously I worked for a publishing company as a science editor.
My primary degree in science is from Trinity College Dublin and I hold a Master’s degree in science communications from Dublin City University.
ResearchRomans’ hot recipe for self-healing concrete unravelled in Pompeii
Discovery of building materials abandoned at construction site reveals secrets of ancient concrete that can set underwater
BusinessUK agrees higher drug prices to secure zero-tariff deal with US
NHS could pay up to 25% more for innovative drugs, but exports will be tariff free for three years
NewsSwiss researchers glad to have rejoined EU science schemes but ponder damage of exclusion
The country officially rejoined Horizon Europe and a range of other programmes in November but what did it cost its science base?
BusinessAkzoNobel-Axalta merger gives coatings firm extra layers
Pursuit of scale drives continued consolidation across coatings sector
BusinessIneos asks EU to intervene over ‘unfair’ chemical imports
Group says 10 key chemicals are being dumped cheaply, harming domestic industry
FeatureNitrous oxide emissions accelerate as agriculture drives climate threat
With N2O emissions up 40% in four decades, scientists are searching for answers. Anthony King looks at potential solutions to keep fertiliser nitrogen in the soil
ResearchBeer yeast leftovers spun into a promising sustainable yarn 50% stronger than wool
Brewery waste can be turned into a cheap, environmentally-friendly textile
BusinessNovartis spends on deals to offset patent losses
$12 billion Avidity acquisition is the latest pipeline-pumping transaction
BusinessBASF sells coatings business to Carlyle in €7.7 billion deal
Deal covers automotive and surface treatment businesses and follows earlier sale of decorative paints
BusinessNovo Nordisk’s new chief cuts 9000 jobs
Danish firm shifts strategy after struggling to capitalise on its weight loss drugs
BusinessPharma sector jolted by unpredictable US tariffs policy
Firms face tough decisions amid Trump’s threatened taxes on pharmaceutical imports and ‘capricious’ approach to tariffs
ResearchLow lithium levels linked to Alzheimer’s
Immune cells’ ability to degrade amyloid-beta peptides restored in mice treated with lithium salt
NewsAs AI-designed drug looks to pass final hurdle, will this tech change drug discovery forever?
AI-led drug for chronic lung disease set to enter phase 3 clinical trials, though experts remain divided on AI’s impact in pharma
BusinessTwo more European crackers to close
Sabic will not reopen UK plant and Dow will close another in Germany
BusinessUS approves twice yearly injection to prevent HIV
Yeztugo (lenacapavir) provided near-total protection against infection in clinical trials
NewsGene-edited crops set to arrive in England, but EU remains divided on them
Crops poised to be grown in England but renegotiation of trade agreement with EU could complicate matters
BusinessMilitary demand strains metal supply chains
Conflict and trade disputes have disrupted global supplies of specialist metals like hafnium, antimony and rare earths
FeatureHibernation awakens interest for drug discovery
With many different species entering torpor for a variety of reasons, scientists are looking to their sleepy secrets for ways to treat human diseases. Anthony King reports
ResearchAn overlooked bonding motif appears in many more proteins than was previously realised
Covalent nitrogen–oxygen–sulfur linkages could be a new target for potential drugs
BusinessTrade deals stave off Trump’s tariffs temporarily
Initial agreements with China and UK have paused trade war, but uncertainty reigns